Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis

Abnormal liver enzymes are seen in 20% of hospitalized patients with COVID-19. The etiology of elevated liver enzymes is thought to be multifactorial including medications and underlying liver disease. The true prevalence and clinical significance of underlying chronic liver diseases (CLD) in COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovalic, Alexander J., Satapathy, Sanjaya K., Thuluvath, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386238/
https://www.ncbi.nlm.nih.gov/pubmed/32725453
http://dx.doi.org/10.1007/s12072-020-10078-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386238/
https://www.ncbi.nlm.nih.gov/pubmed/32725453
http://dx.doi.org/10.1007/s12072-020-10078-2

Ejemplares similares